| 词条 | Triazavirin |
| 释义 |
| IUPAC_name = 2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-7(4H)-one | image = Triazavirin.svg | tradename = | legal_US = Investigational New Drug | legal_status = | bioavailability = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 928659-17-0 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | PubChem = 3113817 | ChemSpiderID = 2367718 | C=5 | H=4 | N=6 | O=3 | S=1 | molecular_weight = 228.189 | smiles = CSc1[nH]n2c(=O)c(nnc2n1)[N+](=O)[O-] | StdInChI = 1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9) | StdInChIKey = IDVQGNMSSHPZSJ-UHFFFAOYSA-N }}Triazavirin (TZV) is a broad-spectrum antiviral drug developed in Russia through a joint effort of Ural Federal University, Russian Academy of Sciences, Ural Center for Biopharma Technologies and Medsintez Pharmaceutical. It has an azoloazine base structure, which represents a new structural class of non-nucleoside antiviral drugs.[1] It was originally developed as a potential treatment for pandemic influenza strains such as H5N1, and most of the testing that has been done has focused on its anti-influenza activity.[2][3][4] However triazavirin has also been found to have antiviral activity against a number of other viruses including tick-borne encephalitis,[5] and is also being investigated for potential application against Lassa fever and Ebola virus disease.[6][7][8][9][10] See also
References1. ^Rusinov VL, Sapozhnikova IM, Ulomskii EN, Medvedeva NR, Egorov VV, Kiselev OI, Deeva EG, Vasin AV, Chupakhin ON. Nucleophilic substitution of nitro group in nitrotriazolotriazines as a model of potential interaction with cysteine-containing proteins. Chemistry of Heterocyclic Compounds 2015;51(3):275-280. doi 10.1007/s10593-015-1695-4 {{RNA antivirals}}{{Filoviridae}}{{antiinfective-drug-stub}}2. ^Loginova SIa, Borisevich SV, Maksimov VA, Bondarev VP, Kotovskaia SK, Rusinov VL, Charushin VN. Investigation of triazavirin antiviral activity against influenza A virus (H5N1) in cell culture. (Russian) Antibiotiki i Khimioterapiia. 2007;52(11-12):18-20. {{PMID|19275052}} 3. ^Karpenko I, Deev S, Kiselev O, Charushin V, Rusinov V, Ulomsky E, Deeva E, Yanvarev D, Ivanov A, Smirnova O, Kochetkov S, Chupakhin O, Kukhanova M. Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication. Antimicrobial Agents and Chemotherapy. 2010 May;54(5):2017-22. doi: 10.1128/AAC.01186-09 {{PMID|20194696}} 4. ^Kiselev OI, Deeva EG, Mel'nikova TI, Kozeletskaia KN, Kiselev AS, Rusinov VL, Charushin VN, Chupakhin ON. A new antiviral drug Triazavirin: results of phase II clinical trial. (Russian). Voprosy Virusologii. 2012 Nov-Dec;57(6):9-12. {{PMID|23477247}} 5. ^Loginova SIa, Borisevich SV, Rusinov VL, Ulomskiĭ UN, Charushin VN, Chupakhin ON. Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture. (Russian). Antibiotiki i Khimioterapiia. 2014;59(1-2):3-5. {{PMID|25051708}} 6. ^{{cite web|title=Target: Ebola|url=http://english.pravda.ru/health/22-12-2014/129359-target_ebola-0/|publisher=Pravda|accessdate=18 January 2015}} 7. ^{{cite web|title=Yekaterinburg pharmacies to sell domestic antiviral drug|url=http://yekaterinburgnews.com/daily-news/yekaterinburg-pharmacies-to-sell-domestic-antiviral-drug/11873/|accessdate=18 January 2015}} 8. ^{{cite web|url=https://www.bbc.co.uk/news/health-29649572|title=Ebola crisis: Vaccine 'too late' for outbreak. BBC News, 17 October 2014|work=BBC News}} 9. ^Kukil Bora. Russia Will Begin Testing Triazavirin, Used For Lassa Fever, And Other Drugs On Ebola: Health Ministry. International Business Times, 12 November 2014 10. ^Darya Kezina. New antiviral drug from Urals will help fight Ebola and other viruses. Russia Beyond the Headlines, 12 November 2014 6 : Antivirals|Experimental drugs|Lactams|Thioethers|Nitrogen heterocycles|Heterocyclic compounds (2 rings) |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。